{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:33:26Z","timestamp":1793414006880,"version":"4.5.0"},"reference-count":45,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15361","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:34:59Z","timestamp":1761305699000},"page":"1-8","source":"Crossref","is-referenced-by-count":2,"title":["Combined BRAF\/MEK inhibition for BRAF\u2011mutant melanoma brain metastases in pregnancy: A case report"],"prefix":"10.3892","volume":"31","author":[{"given":"Jaroslav","family":"Melus","sequence":"first","affiliation":[{"name":"2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Jezberova","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance Imaging, Dr. Magnet Ltd., Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mikulajova","sequence":"additional","affiliation":[{"name":"Department of Neonatology, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Gerincova","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Slovak Medical University, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Karlik","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Straka","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Krivosik","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valkovic","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Timarova","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, Comenius University Bratislava, Faculty of Medicine, University Hospital Bratislava, Bratislava 833 05, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"key20251205105242_b1-ol-31-1-15361","first-page":"1071","article-title":"Cutaneous melanoma: From pathogenesis to therapy (Review)","volume":"52","author":"Leonardi","year":"2018","journal-title":"Int J Oncol"},{"key":"key20251205105242_b2-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer data base report on cutaneous and noncutaneous melanoma: A summary of 84,836 cases from the past decade. The American college of surgeons commission on cancer and the American cancer society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"key20251205105242_b3-ol-31-1-15361","first-page":"161","article-title":"Cutaneous malignant melanoma: A primary care perspective","volume":"85","author":"Shenenberger","year":"2012","journal-title":"Am Fam Physician"},{"key":"key20251205105242_b4-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma","volume":"88","author":"Sampson","year":"1998","journal-title":"J Neurosurg"},{"key":"key20251205105242_b5-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"e1209","DOI":"10.1634\/theoncologist.2019-0747","article-title":"Prognosis and management of BRAF V600E-mutated pregnancy-associated melanoma","volume":"25","author":"Ziogas","year":"2020","journal-title":"Oncologist"},{"key":"key20251205105242_b6-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ad.2011.07.007","article-title":"Melanoma and pregnancy","volume":"102","author":"Serrano-Ortega","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"key20251205105242_b7-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cncr.20925","article-title":"Malignant melanoma in pregnancy: A population-based evaluation","volume":"103","author":"O'Meara","year":"2005","journal-title":"Cancer"},{"key":"key20251205105242_b8-ol-31-1-15361","first-page":"156","article-title":"Malignant melanoma and pregnancy ten questions","volume":"164","author":"Dillman","year":"1996","journal-title":"West J Med"},{"key":"key20251205105242_b9-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"28","DOI":"10.14740\/wjon1177","article-title":"Cancer during pregnancy: The oncologist overview","volume":"10","author":"Hepner","year":"2019","journal-title":"World J Oncol"},{"key":"key20251205105242_b10-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","article-title":"Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infant","volume":"21","author":"Alexander","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20251205105242_b11-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): A multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"key":"key20251205105242_b12-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/S1470-2045(21)00545-3","article-title":"Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): Final results of an open-label, multicentre, phase 2 study","volume":"22","author":"Tawbi","year":"2021","journal-title":"Lancet Oncol"},{"key":"key20251205105242_b13-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1200\/JCO.21.02961","article-title":"Sequencing of ipilimumab plus nivolumab and encorafenib plus binimetinib for untreated BRAF-mutated metastatic melanoma (SECOMBIT): A randomized, three-arm, open-label phase II trial","volume":"41","author":"Ascierto","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20251205105242_b14-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"e00142","DOI":"10.1016\/j.crwh.2019.e00142","article-title":"Treatment of metastatic malignant melanoma during pregnancy with a BRAF kinase inhibitor","volume":"24","author":"Pagan","year":"2019","journal-title":"Case Rep Womens Health"},{"key":"key20251205105242_b15-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1200\/JCO.2012.45.2870","article-title":"Treatment of metastatic malignant melanoma with vemurafenib during pregnancy","volume":"31","author":"Maleka","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20251205105242_b16-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000487128","article-title":"Severe adverse reaction to vemurafenib in a pregnant woman with metastatic melanoma","volume":"11","author":"de Haan","year":"2018","journal-title":"Case Rep Oncol"},{"key":"key20251205105242_b17-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/CMR.0000000000000600","article-title":"Partial response of metastatic melanoma to BRAF-inhibitor-monotherapy in a pregnant patient with no fetal toxicity","volume":"29","author":"Marc\u00e9","year":"2019","journal-title":"Melanoma Res"},{"key":"key20251205105242_b18-ol-31-1-15361","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"key20251205105242_b19-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"key20251205105242_b20-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American joint committee on cancer (AJCC) melanoma staging system: Implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20251205105242_b21-ol-31-1-15361","article-title":"Bancroft's Theory and Practice of Histological Techniques","author":"Suvarna","year":"2018","edition":"8th edition"},{"key":"key20251205105242_b22-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1354\/vp.42-4-405","article-title":"Technical aspects of immunohistochemistry","volume":"42","author":"Ramos-Vara","year":"2005","journal-title":"Vet Pathol"},{"key":"key20251205105242_b23-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J Cutan Pathol"},{"key":"key20251205105242_b24-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1213\/00000539-195301000-00041","article-title":"A proposal for a new method of evaluation of the newborn infant","volume":"32","author":"Apgar","year":"1953","journal-title":"Curr Res Anesth Analg"},{"key":"key20251205105242_b25-ol-31-1-15361","article-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2019","edition":"4th edition"},{"key":"key20251205105242_b26-ol-31-1-15361","article-title":"Bayley scales of Infant and Toddler Development","author":"Bayley","year":"2006","edition":"3rd edition"},{"key":"key20251205105242_b27-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"key20251205105242_b28-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1525-5050(03)00004-0","article-title":"Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"key20251205105242_b29-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"key20251205105242_b30-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"key20251205105242_b31-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"key20251205105242_b32-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2020.02.021","article-title":"Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition-update 2019","volume":"130","author":"Ugurel","year":"2020","journal-title":"Eur J Cancer"},{"key":"key20251205105242_b33-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ejca.2013.11.002","article-title":"Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study","volume":"50","author":"Dummer","year":"2014","journal-title":"Eur J Cancer"},{"key":"key20251205105242_b34-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ajog.2023.11.054","article-title":"36 Evaluation of transplacental transfer of cancer therapies in melanoma via the perfused human placental model","volume":"230","author":"Heggarty","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"key20251205105242_b35-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.esmoop.2021.100248","article-title":"Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy","volume":"6","author":"Hassel","year":"2021","journal-title":"ESMO Open"},{"key":"key20251205105242_b36-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/cancers16122173","article-title":"Melanoma in pregnancy-diagnosis, treatment, and consequences for fetal development and the maintenance of pregnancy","volume":"16","author":"Pelczar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20251205105242_b37-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/14740338.2021.1893299","article-title":"Risks of molecular targeted therapies to fertility and safety during pregnancy: A review of current knowledge and future needs","volume":"20","author":"Lorenzi","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"key20251205105242_b38-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1210\/er.2017-00232","article-title":"The RASopathy family: Consequences of germline activation of the RAS\/MAPK pathway","volume":"39","author":"Tajan","year":"2018","journal-title":"Endocr Rev"},{"key":"key20251205105242_b39-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/ddg.12596","article-title":"New systemic agents in dermatology with respect to fertility, pregnancy, and lactation","volume":"13","author":"Grunewald","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"key20251205105242_b40-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"key":"key20251205105242_b41-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","article-title":"Cutaneous melanoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"36","author":"Amaral","year":"2025","journal-title":"Ann Oncol"},{"key":"key20251205105242_b42-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1200\/OP.20.00077","article-title":"Multidisciplinary management of cancer during pregnancy","volume":"16","author":"Silverstein","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"key20251205105242_b43-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"e100037","DOI":"10.1200\/EDBK_100037","article-title":"Patient-centered care in the management of cancer during pregnancy","volume":"43","author":"Sorouri","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20251205105242_b44-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"e13145","DOI":"10.1111\/dth.13145","article-title":"Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced\/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis","volume":"33","author":"Garz\u00f3n-Orjuela","year":"2020","journal-title":"Dermatol Ther"},{"key":"key20251205105242_b45-ol-31-1-15361","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/CCID.S410723","article-title":"Construction and identification of an NLR-associated prognostic signature revealing the heterogeneous immune response in skin cutaneous melanoma","volume":"16","author":"Geng","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:52:47Z","timestamp":1764924767000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,24]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15361","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}